GGrantIndex
Sort

15,440 grants matching organoids

Elucidating the Immune Suppressive Mechanism of SIGLEC-15 in the Tumor Microenvironment

$549,292
Jun Wang · New York University School Of Medicine · R01 · FY2024 · CA

Coordinated regeneration of lung epithelial and endothelial compartments

$549,195
Andrew Vaughan · University Of Pennsylvania · R01 · FY2022 · HL

Targeting Focal Adhesion Kinase to Improve RT-inducted Tumor Immunity

$549,025
David G Denardo · Washington University · R01 · FY2021 · CA

Specificity, Phenotype and Function of Pancreatic CD8 T Cells in Human Type 1 Diabetes

$549,000
Estefania Quesada Masachs · La Jolla Institute For Immunology · R01 · FY2023 · AI

Core C: Experimental Models

$548,945
Michael E. Berens · Cleveland Clinic Lerner Com-Cwru · P01 · FY2022 · CA

Targeting WEE1 in uterine serous or p53-mutated uterine cancer

$548,921
Joyce Liu · Dana-Farber Cancer Inst · P01 · FY2025 · CA

Epigenetic Regulation of Skin Regional Specificity

$548,887
Cheng-Ming Chuong · University Of Southern California · R01 · FY2023 · AR

Understanding breast cancer progression as a defect in the mechanics of tissue self-organization

$548,840
Zev Jordan Gartner · University Of California, San Francisco · U01 · FY2024 · CA

Group 2 Innate Lymphoid Cell Regulation of Pancreatic Cancer Immunity

$548,714
Vinod P Balachandran · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA

Synergistic combinatorial DNA damage response/repair inhibition and Sacituzumab Govitecan in triple-negative breast cancer

$548,587
Leif W Ellisen · Massachusetts General Hospital · R01 · FY2023 · CA

Impact of CLDN1 inhibition on chemoresistance and metastasis of colon cancer

$548,542
Punita Dhawan · University Of Nebraska Medical Center · R01 · FY2023 · CA

A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC

$548,526
Chengyu Liang · Wistar Institute · R01 · FY2024 · CA

Molecular Drivers of Human Gliogenesis

$548,336
Steven A Sloan · Emory University · R01 · FY2023 · MH

Core C: Experimental Models

$548,201
Michael E. Berens · Cleveland Clinic Lerner Com-Cwru · P01 · FY2023 · CA

REGULATION OF ATROPHY-INDUCED PROGENITOR CELLS IN THE GASTRIC CORPUS

$548,144
Jason C Mills · Baylor College Of Medicine · R01 · FY2023 · DK

Wnt signaling in the alveolar niche

$548,054
Edward E Morrisey · University Of Pennsylvania · R01 · FY2020 · HL

Overcoming primary and secondary resistance in wild-type BRAF melanoma

$548,033
Andrew E Aplin · Wistar Institute · P01 · FY2020 · CA

Engineering a Kidney Organoid Model to Investigate Fibronectin-TGF-beta Signaling in Renal Fibrosis

$548,031
Christopher Lemmon · Virginia Commonwealth University · · FY2023 · ENG

Characterization of a commensal enteric virus

$548,029
Ken Hashigiwa Cadwell · New York University School Of Medicine · R01 · FY2022 · DK

Kidney Injury Molecule-1 in Epithelial Repair

$547,940
Joseph Vincent Bonventre · Brigham And Women'S Hospital · R01 · FY2023 · DK

Kidney Injury Molecule-1 in Epithelial Repair

$547,940
Joseph Vincent Bonventre · Brigham And Women'S Hospital · R01 · FY2021 · DK

Kidney Injury Molecule-1 in Epithelial Repair

$547,940
Joseph Vincent Bonventre · Brigham And Women'S Hospital · R01 · FY2022 · DK

Neurodevelopment of Tourette syndrome

$547,846
Flora M Vaccarino · Yale University · R01 · FY2020 · MH

Project 3: Long Non-Coding RNAs and Cancer

$547,839
David L Spector · Cold Spring Harbor Laboratory · P01 · FY2019 · CA

Therapeutic evaluation of targeting Tau Tubulin kinase-1 in Alzheimer’s disease

$547,750
Seiko Ikezu · Mayo Clinic Jacksonville · R01 · FY2024 · AG